For example, in one routine examination of freshly drawn whole blood from 40 clinically normal individuals, a general cellular stickiness was observed with massive red-cell agglutination, irregular cell size and shape, and extraneous intracellular debris including pleomorphic granules, especially in the extremities. This manifestation seems to account for poor tissue and organ oxygenation, leading to poor blood circulation and tissue function. However, when product is administered, blood drawn as soon as 20 minutes later shows obvious improvement: Red cells have plumped up and are of a more homogenous size and shape. Cells have "lost" their prior stickiness, appearing less viscous and newly "teflonized" to move much more freely and without agglutination. Capillary perfusion is markedly improved. This observation alone suggests the product could be enormously useful in the prevention and/or management of stroke and heart attack.